FDA Approves Rx-to-OTC Switch of Sklice for Head Lice Treatment
Each gram of lotion contains 5mg of ivermectin, the same as the prescription strength.
Scabies and Lice
Head Lice Treatment Xeglyze Gets FDA Approval
The FDA has approved Xeglyze™ (abametapir; Dr. Reddy’s Laboratories) for the treatment of head lice infestation in patients aged 6 months and older.
Pesticide-Free Lice Treatment Gets FDA Clearance
Resultz is an odorless treatment that kills and removes head lice with a 5 minute application time; this is the shortest time frame associated with currently available lice products.
Parasitic Topical May Aid Skin Inflammation Diseases
Ivermectin (IVM) has anti-inflammatory properties that could be beneficial in treatment of T-cell mediated skin inflammatory diseases, according to an experimental study published online in Allergy.
Growing Resistance May Make OTC Head Lice Treatments Obsolete
A literature review of head lice treatments in the U.S. found a significant decline in the effectiveness of over-the-counter (OTC) permethrin and synergized pyrethrins (collectively pyrethroids) treatments, indicating a need for judicious use of effective treatments by clinicians.
Scabies Treatment No Longer Available
Wockhardt/Morton Grove Pharmaceuticals announced the discontinuation of Lindane Lotion 1%. The Companies have decided to stop manufacturing this product as of June 2, 2016.
Lycelle Head Lice Removal Kit Now Available without Rx
Mission Pharmacal announced that Lycelle Head Lice Removal Kit (sodium laureth sulfate, isopropanol, citronellyl acetate, hypromellose, methyl salicylate, methylparaben, citric acid) is now available without a prescription.
Treatment-Resistant Lice Common Across the U.S.
Treatment-resistant lice with one or more genetic mutations have been identified in at least 25 states, according to research presented at the 250th National Meeting & Exposition of the American Chemical Society (ACS).
Guidelines Updated for Lice Infestation Among Children
American Academy of Pediatrics also gives advice on best medicines to treat infestation
Natroba Now Approved for Younger Children with Head Lice
ParaPRO announced that the Food and Drug Administration (FDA) has approved an expanded age range for Natroba (spinosad) Topical Suspension, to include children 6 months of age and older who have pediculosis capitis (head lice).
